Franco Nolé

Franco Nolé

UNVERIFIED PROFILE

Are you Franco Nolé?   Register this Author

Register author
Franco Nolé

Franco Nolé

Publications by authors named "Franco Nolé"

Are you Franco Nolé?   Register this Author

73Publications

1818Reads

50Profile Views

Breast implant-associated anaplastic large cell lymphoma: A comprehensive review.

Cancer Treat Rev 2020 Mar 13;84:101963. Epub 2020 Jan 13.

Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2020.101963DOI Listing
March 2020

The Role of Obesity in Renal Cell Carcinoma Patients: Clinical-Pathological Implications.

Int J Mol Sci 2019 Nov 13;20(22). Epub 2019 Nov 13.

Section of Pathological Anatomy, United Hospitals, School of Medicine, Polytechnic University of the Marche Region, 60126 Ancona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms20225683DOI Listing
November 2019

Prognostic role of the cumulative toxicity in patients affected by metastatic renal cells carcinoma and treated with first-line tyrosine kinase inhibitors.

Anticancer Drugs 2017 02;28(2):206-212

aMedical Oncology Division of Urogenital and Head and Neck Tumours, European Institute of Oncology bDivision of Urologic Cancer Surgery, European Institute of Oncology, Milan cMedical Oncology Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0000000000000439DOI Listing
February 2017

Bladder preservation in non-metastatic muscle-invasive bladder cancer (MIBC): a single-institution experience.

Ecancermedicalscience 2016 14;10:657. Epub 2016 Jul 14.

Department of Oncology and Haemato-oncology, University of Milan, 20122 Milan, Italy; Division of Radiotherapy, European Institute of Oncology IRCCS, 20141 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3332/ecancer.2016.657DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970626PMC
August 2016

Inside the 2015 ASCO Genitourinary Cancers Symposium.

Future Oncol 2015 ;11(13):1859-62

Department of Medical Oncology, AOU Ospedali Riuniti - Polytechnic University of the Marche Region, Ancona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.15.103DOI Listing
April 2016

Prognostic Role of PD-L1 Expression in Renal Cell Carcinoma. A Systematic Review and Meta-Analysis.

Target Oncol 2016 Apr;11(2):143-8

Medical Oncology, I.R.C.C.S. San Matteo University Hospital Foundation, Piazzale C. Golgi 19, 27100, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-015-0392-7DOI Listing
April 2016

Is there still a role for sorafenib in metastatic renal cell carcinoma? A systematic review and meta-analysis of the effectiveness of sorafenib over other targeted agents.

Crit Rev Oncol Hematol 2016 Mar 19;99:324-31. Epub 2016 Jan 19.

Division of Medical Oncology, Genitourinary Unit; European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2016.01.014DOI Listing
March 2016

Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development.

Future Oncol 2016 Feb 19;12(3):373-87. Epub 2015 Nov 19.

Department of Clinical & Experimental Medicine, Division of Pharmacology, University of Pisa, 56126 Pisa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.15.306DOI Listing
February 2016

The incidence and relative risk of cardiovascular toxicity in patients treated with new hormonal agents for castration-resistant prostate cancer.

Eur J Cancer 2015 Sep 10;51(14):1970-7. Epub 2015 Jul 10.

Medical Oncology Division of Urogenital and Head & Neck Tumours, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2015.06.106DOI Listing
September 2015

Estramustine phosphate sodium in heavily pretreated patients with metastatic breast cancer: a retrospective consecutive case series.

Int J Clin Oncol 2015 Feb 12;20(1):90-4. Epub 2014 Apr 12.

Division of Medical Oncology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-014-0694-2DOI Listing
February 2015

Reply to letter by Ieni et al.

Eur J Cancer 2014 Mar 5;50(5):1038-9. Epub 2014 Feb 5.

Department of Pathology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2014.01.015DOI Listing
March 2014

Brain metastases from colorectal cancer: main clinical factors conditioning outcome.

Int J Colorectal Dis 2014 Feb 26;29(2):201-8. Epub 2013 Oct 26.

Gastrointestinal and Neuroendocrine Tumors Unit, European Institute of Oncology, via Ripamonti 435, Milan, 20141, Italy,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00384-013-1781-yDOI Listing
February 2014

Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy.

Breast 2014 Feb 7;23(1):44-9. Epub 2013 Nov 7.

Unit of Investigative Clinical Oncology (INCO), Fondazione del Piemonte per l'Oncologia, Institute for Cancer Research and Treatment (IRCCs), Candiolo, Italy; Division of Medical Oncology, Fondazione del Piemonte per l'Oncologia, Institute for Cancer Research and Treatment (IRCCs), Candiolo, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2013.10.005DOI Listing
February 2014

Targeting the subtypes of breast cancer: rethinking investigational drugs.

Expert Opin Investig Drugs 2012 Feb 10;21(2):191-204. Epub 2012 Jan 10.

Division of Medical Oncology, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milano, Italia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2012.651456DOI Listing
February 2012

Prognostic value of circulating tumor cells in primary and metastatic breast cancer.

Expert Rev Anticancer Ther 2012 Feb;12(2):203-14

European Institute of Oncology, Medical Care Unit, Department of Medical Oncology, Ripamonti Street 435, Milan 20141, Italy.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/18/20/5701.ful
Web Search
http://www.tandfonline.com/doi/full/10.1586/era.11.208
Publisher Site
http://dx.doi.org/10.1586/era.11.208DOI Listing
February 2012

Hormone-receptor expression and activity of trastuzumab with chemotherapy in HER2-positive advanced breast cancer patients.

Cancer 2012 Jan 19;118(1):17-26. Epub 2011 May 19.

Division of Medical Oncology 1, Piedmont Foundation for Oncology, Institute for Cancer Research and Treatment, Candiolo, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.26162DOI Listing
January 2012

Successful treatment with GEMOX in patient with metastatic pancreatic adenosquamous carcinoma.

Tumori 2011 Mar-Apr;97(2):239-42

European Institute of Oncology, Medical Care Unit, Department of Medical Oncology, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1700/667.7792DOI Listing
July 2011

Underuse of anthracyclines in women with HER-2+ advanced breast cancer.

Oncologist 2010 24;15(7):665-72. Epub 2010 Jun 24.

Division of Medical Oncology I, Fondazione del Piemonte per L'Oncologia, Institute for Cancer Research and Treatment, 10060 Candiolo, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2010-0016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228005PMC
December 2010

Changes in circulating tumor cell detection in patients with localized breast cancer before and after surgery.

Ann Surg Oncol 2010 Jun 5;17(6):1539-45. Epub 2010 Feb 5.

Unit of Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-010-0918-2DOI Listing
June 2010

Male breast cancer.

Future Oncol 2010 Jun;6(6):985-91

Division of Senology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.10.55DOI Listing
June 2010

Rethinking TNM: a breast cancer classification to guide to treatment and facilitate research.

Breast J 2009 May-Jun;15(3):291-5

Scientific Director European Institute of Oncology, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1524-4741.2009.00719.xDOI Listing
October 2009

Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer.

Cancer Chemother Pharmacol 2009 Sep 31;64(4):673-80. Epub 2009 Jan 31.

Department of Medicine, European Institute of Oncology, Milan, Italy.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00280-008-0915-3
Publisher Site
http://dx.doi.org/10.1007/s00280-008-0915-3DOI Listing
September 2009

Simplified FOLFIRI in pre-treated patients with metastatic gastric cancer.

Cancer Chemother Pharmacol 2009 Jul 26;64(2):301-6. Epub 2008 Nov 26.

Department of Medical Oncology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-008-0871-yDOI Listing
July 2009

Fulvestrant in heavily pre-treated patients with advanced breast cancer: results from a single compassionate use programme centre.

Breast Cancer Res Treat 2007 Nov 27;106(1):97-103. Epub 2007 Jan 27.

Unit for Medical Care, Division of Medical Oncology, European Institute of Oncology, 20141, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-006-9481-8DOI Listing
November 2007

Primary therapy with ECF in combination with a GnRH analog in premenopausal women with hormone receptor-positive T2-T4 breast cancer.

Breast 2007 Feb 5;16(1):73-80. Epub 2006 Sep 5.

Research Unit of Medical Senology, Department of Medicine, European Institute of Oncology, via Ripamonti 435, 20141 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2006.06.005DOI Listing
February 2007

Erlotinib-induced breast cancer regression.

Ann Pharmacother 2006 Nov 24;40(11):2043-7. Epub 2006 Oct 24.

Medical Care Unit, Department of Medicine, European Institute of Oncology, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1345/aph.1H252DOI Listing
November 2006

Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy.

Breast Cancer Res 2006 7;8(1):R4. Epub 2005 Dec 7.

Department of Medicine, Division of Medical Oncology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr1366DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1413988PMC
March 2006

Perception that oral anticancer treatments are less efficacious: development of a questionnaire to assess the possible prejudices of patients with cancer.

Breast Cancer Res Treat 2005 Aug;92(3):265-72

Division of Medical Oncology, Day Hospital Unit & Unit of Psycho-oncology, Department of Medicine, European Institute of Oncology, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-005-3376-yDOI Listing
August 2005

Intrathecal chemotherapy in carcinomatous meningitis from breast cancer.

Anticancer Res 2002 Sep-Oct;22(5):3057-9

Division of Medical Oncology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy.

View Article

Download full-text PDF

Source
February 2003